# OnCo record pi3k-akt-mtor (pathway). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/pathways/pi3k-akt-mtor/>
  a schema:BioChemEntity ;
  onco:kind "pathway" ;
  schema:identifier "pi3k-akt-mtor" ;
  schema:name "PI3K / AKT / mTOR"@en ;
  schema:description "The cell's 'grow and survive' circuit. Growth signals from the surface switch on PI3K, which switches on AKT, which switches on mTOR, which builds proteins and blocks self-destruction."@en ;
  schema:url <https://onco.cc/pathways/pi3k-akt-mtor/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/PI3K/AKT/mTOR_pathway> ;
  owl:sameAs <http://www.wikidata.org/entity/Q7119288> ;
  schema:citation <https://en.wikipedia.org/wiki/PI3K/AKT/mTOR_pathway> ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/gallbladder/> ;
  onco:targets <https://onco.cc/targets/pik3ca/>, <https://onco.cc/targets/akt/>, <https://onco.cc/targets/her2/>, <https://onco.cc/targets/egfr/> ;
  onco:drugs <https://onco.cc/drugs/capivasertib/>, <https://onco.cc/drugs/inavolisib/>, <https://onco.cc/drugs/gedatolisib/> .
